Pharma companies spent almost $3M on marketing in Vermont for FY 2008
Pharma Compliance Alert, April 22, 2009
Pharmaceutical manufacturers paid almost $3 million to 2,280 doctors, hospitals, universities, and others to market their drugs in fiscal year 2008, according to the Vermont Attorney General’s (AG) sixth annual Report on Pharmaceutical Marketing Disclosures.
Almost half of the reported marketing expenditures were for speaking fees and payments, while nearly 25% was for marketing. Almost 60% of the expenditures were direct payments to recipients in the form of cash or check.
Read more about pharmaceutical marketing disclosures in Vermont.
Most Popular
- Articles
-
- Jury sides with blood lab technician in New Jersey whistleblower case
- Note from Hugh
- Five tips for an effective hospital patient safety program
- Q/A: Should we use modifier -Q0 to override edits for ICDs?
- Questions surround when time starts for proposed inpatient presumption
- Overnight physicians in ICU show little effect on outcomes
- QAPI is coming: Is your facility preparing for its arrival?
- Tip: Review codes that are now packaged
- CMS releases updated MDS 3.0 RAI User's Manual
- Note from the instructor: CMS clarifies payment amount to be applied to payment caps and manual review thresholds for outpatient therapy services provided by critical access hosptials
- E-mailed
-
- Questions surround when time starts for proposed inpatient presumption
- Jury sides with blood lab technician in New Jersey whistleblower case
- Q/A: Should we use modifier -Q0 to override edits for ICDs?
- Overnight physicians in ICU show little effect on outcomes
- Tip: Review codes that are now packaged
- QAPI is coming: Is your facility preparing for its arrival?
- ACDIS/AHIMA brief provides guidance on query best practices
- Five tips for an effective hospital patient safety program
- Maine comes in first in hospital safety
- Surgical residents disapprove of duty hour restrictions
- Searched